Keyphrases
Pharmacodynamic Interactions
100%
Anticoagulants
100%
Thrombin Generation
100%
Inter-individual Variation
100%
Anticoagulant Drugs
100%
Thrombin
50%
Unfractionated Heparin
50%
Coefficient of Variation
50%
Endogenous Thrombin Potential
50%
Peak Height
50%
Pentasaccharide
50%
Otamixaban
50%
Dermatan Sulfate
50%
Melagatran
50%
Anticoagulation
25%
Heparin
25%
Antithrombin
25%
Inhibitory Effect
25%
Factor Xa
25%
Platelet-poor Plasma
25%
Pharmacokinetics
25%
Calibrated Automated Thrombinography
25%
Pharmacodynamics
25%
Apparently Healthy Subjects
25%
Direct Inhibitors
25%
INIS
drugs
100%
variations
100%
anticoagulants
100%
thrombin
100%
inhibition
50%
concentration
37%
heparin
37%
height
25%
peaks
25%
sulfates
25%
populations
12%
plasma
12%
Medicine and Dentistry
Thrombin
100%
Antithrombotic
100%
Pharmacodynamics
100%
Heparin
37%
Anticoagulant
25%
Pentasaccharide
25%
Dermatan Sulfate
25%
Melagatran
25%
Otamixaban
25%
Antithrombin
12%
Prothrombinase
12%
Thrombocyte Poor Plasma
12%
Pharmacokinetics
12%
Anticoagulation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Thrombin
100%
Pharmacodynamics
100%
Heparin
37%
Dermatan Sulfate
25%
Pentasaccharide
25%
Otamixaban
25%
Melagatran
25%
Normal Human
12%
Blood Clotting Factor 10a
12%
Antithrombin
12%
Pharmacokinetics
12%
Neuroscience
Thrombin
100%
Antithrombotic
100%
Heparin
37%
Anticoagulant
25%
Pentasaccharide
25%
Dermatan Sulfate
25%
Blood Clotting Factor 10a
12%
Antithrombin
12%
Blood Plasma
12%
Platelet
12%
Pharmacokinetics
12%
Agricultural and Biological Sciences
Thrombin
100%
Heparin
37%
Sulfate
25%
Platelet-Poor Plasma
12%
Pharmacokinetics
12%